A jury finds Elizabeth Holmes guilty of fraud
Theranos’s founder captured the imagination of investors, political bigwigs and Hollywood alike
ON JANUARY 3RD, after seven days of deliberation, a 12-member jury in Silicon Valley found Elizabeth Holmes, the entrepreneur behind a blood-testing startup, guilty of four counts of fraudulently deceiving investors. Each count carries a prison term of up to 20 years; no date has been set for her sentencing. She was acquitted of four charges of deceiving patients and doctors; on three others the jury were deadlocked. The verdict, against which Ms Holmes’s lawyers are expected to appeal, marks the collapse of a career that beguiled the media, politicians and investors.
This article appeared in the Business section of the print edition under the headline “Blood will have blood”
Business January 8th 2022
- Just how big in media does Apple want to be?
- Streaming giants get more serious about children’s shows
- A jury finds Elizabeth Holmes guilty of fraud
- Will the cloud business eat the 5G telecoms industry?
- Cars meet chips in Sin City
- Why workers are fleeing the hospitality sector
- The rise of performative work
From the January 8th 2022 edition
Discover stories from this section and more in the list of contents
Explore the editionDiscover more
Could seaweed replace plastic packaging?
Companies are experimenting with new ways to reduce plastic waste
Has Sequoia Capital outgrown its business model?
Venture capital’s hardiest perennial gets back to its roots
On stupid rules and quick wins
Why every boss can benefit from asking employees what most infuriates them
TikTok wants Western consumers to shop like the Chinese
It still has some convincing to do
Will the trouble ever end for Volkswagen and its rivals?
From strikes to Trump tariffs, calamities abound
After Northvolt’s failure, who will make Europe’s EV batteries?
The continent looks ever more reliant on Asian producers